Skip to content
Trial Eligibility
Menu

Crohn's Disease Clinical Trials near New York, NY

38 studies for Crohn's Disease are recruiting at 88 sites within 50 miles of New York, New York, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Crohn's Disease trials in the US or all trials near New York.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Crohn's Disease studies enrolling near New York

Showing 38 studies, nearest first.
  1. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    NCT07184931

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Columbia University Medical Center-Site Number: 8400138 (New York, NY); Manhattan Clinical Research, LLC-Site Number: 8400069 (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    10 sites within 50 mi
  2. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    NCT06581328

    • Phase 4
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: New York Gastroenterology Associates (New York, NY); IMIDeology (Elmhurst, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  3. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    NCT03816345

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Laura and Isaac Perlmutter Cancer Center at NYU Langone (New York, NY); NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  4. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

    NCT06430801

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 5078) (New York, NY); New York Gastroenterology Associates ( Site 5013) (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  5. A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819878

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Lenox Hill Hospital (New York, NY); Mount Sinai Hospital - IBD Clinical Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  6. A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    NCT07184944

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: NYU Langone Health-Site Number: 8400091 (New York, NY); New York Gastroenterology Associates-Site Number: 8400009 (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  7. A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

    NCT07196722

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Inflammatory Bowel Disease Center at NYU Langone (New York, NY); Lenox Hill Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  8. A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

    NCT05509777

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest sites: Columbia University Medical Center/New York Presbyterian (New York, NY); Icahn School of Medicine at Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  9. Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

    NCT05781152

    • Phase 4
    • Ages 6 to 17 years
    • Sex: All

    Nearest sites: Columbia University Medical Center (New York, NY); Cohen Children's Medical Center of NY (Lake Success, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  10. A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

    NCT05923073

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest sites: Icahn School of Medicine at Mount Sinai (New York, NY); Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  11. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

    NCT06548542

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Northwell Health-Lenox Hill Hospital /ID# 265527 (New York, NY); Nyu Langone Long Island Clinical Research Associates - Lake Success /ID# 265566 (Lake Success, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  12. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

    NCT05230173

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Cornell University (New York, NY); NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

    NCT05995353

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest sites: Icahn School of Medicine at Mount Sinai /ID# 254880 (New York, NY); Goryeb Childrens Hospital /ID# 256452 (Morristown, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. Behavioral Therapy for Crohn's Disease

    NCT06512597

    • Interventional
    • Ages 18 to 65 years
    • Sex: All

    Nearest sites: Icahn School of Medicine at Mount Sinai (New York, NY); New York Gastroenterology Associates (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

    NCT06937099

    • Phase 3
    • Ages 18 to 70 years
    • Sex: All

    Nearest sites: New York Gastroenterology Associates (New York, NY); Care Access - Yonkers (Yonkers, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. Autologous Stem Cell Transplant for Crohn's Disease

    NCT03219359

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Icahn School of Medicine at Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis

    NCT03256240

    • Interventional
    • Ages 18 to 90 years
    • Sex: All

    Nearest site: Weill Cornell Medical College (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Low Dose IL-2 for the Treatment of Crohn's Disease

    NCT04263831

    • Phase 1/2
    • Ages 12 to 80 years
    • Sex: All

    Nearest site: Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

    NCT04844606

    • Phase 3
    • Ages 2 to 19 years
    • Sex: All

    Nearest site: Icahn School of Medicine at Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation

    NCT06001450

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Icahn School of Medicine at Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

    NCT06045754

    • Phase 4
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

    NCT06233461

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH) (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

    NCT06274554

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Weill Cornell Medicine (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

    NCT06332534

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Icahn School of Medicine at Mount Sinai /ID# 262216 (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Helmsley 3.0: Abbreviated MRE

    NCT06533228

    • Observational
    • Ages 10 years and older
    • Sex: All

    Nearest site: NYU Langone (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

    NCT06651281

    • Phase 3
    • Ages Any age
    • Sex: All

    Nearest site: New York Gastroenterology Associates ( Site 0253) (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Treatment of Moderate to Severe Refractory Crohn's Disease

    NCT06721962

    • Phase 1/2
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Mount Sinai Health Systems (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

    NCT06750731

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease

    NCT06918808

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Columbia University Irving Medical Center/NYPH (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

    NCT06976853

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Icahn School of Medicine at Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

    NCT07113522

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Mirador Therapeutics Selected Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Zymfentra (Infliximab-dyyb) REal World Cohort STudy

    NCT07237516

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: New York University (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease

    NCT07298421

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

    NCT07499232

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: New York Gastroenterology Associates (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

    NCT07577843

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: New York Gastroenterology Associates (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    NCT07697456

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: New York Gastroenterology Associates - Upper East Side /ID# 281767 (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819891

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Ellipsis Research Group (Brooklyn, NY); Intercity Gastroenterology (Fresh Meadows, NY)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  38. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

    NCT04779320

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest sites: The Steven and Alexandra Cohen Childrens Medical Center of New York - BRANY - PPDS (New Hyde Park, NY); Goryeb Children's Hospital (Morristown, NJ)

    Distance to nearest recruiting site
    ~17 mi (city-level)
    Recruiting sites
    3 sites within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Crohn's Disease clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.